EC Microbiology

Mini Review Volume 22 Issue 6 - 2028

Hantavirus Infections: A Mini-Review of the Literature

Ruqaiyah J Hussain1 and Suleiman Al-Obeid2*

1Lab Medicine and Blood Bank, Mohammed Bin Khalifa Bin Salman AL Khalifa Specialist, Cardiac Center (MKCC), Kingdom of Bahrain
2Consultant of Clinical Microbiology, Paris, France

*Corresponding Author: Suleiman Al-Obeid, Consultant of Clinical Microbiology, Paris, France. E-mail ID: obeidjacques@yahoo.com; Obeid_jacques@hotmail.com.
Received: June 03, 2026; Published: June 23, 2026



Hantavirus can cause various clinical manifestations mainly categorised as: hemorrhagic fever with renal syndrome HFRS and hantavirus pulmonary syndrome HPS. It belongs to the family Bunyaviridae that gets transmitted through rodents, bats and several insectivores species. There are various species which are getting discovered on a regular basis. There are various immune responses noticed due to the intervention of hantavirus in a host There are various commercial vaccines found against hantavirus, in which HANTAVAX - Korean commercial vaccine. This mini review aims to present the history of hantavirus, it’s all aspects, its effect over the world, public health and spread awareness.

Keywords: Hantavirus; History; Disease; Epidemiology; Hosts; Prevention

  1. Baheerati MM and Devi RG. “Obesity in relation to infertility”. Research Journal of Pharmacy and Technology7 (2018): 3183-3185.
  2. Samuel AR and Devi MG. “Geographical distribution and occurrence of endemic goitre”. Research Journal of Pharmacy and Technology8 (2015): 973-978.
  3. Jonsson CB., et al. “A global perspective on hantavirus ecology, epidemiology, and disease”. Clinical Microbiology Reviews 2 (2010): 412-441.
  4. Harsha L., et al. “Systemic approach to management of neonatal jaundice and prevention of kernicterus”. Research Journal of Pharmacy and Technology 8 (2015): 1087-1092.
  5. Sulleiro E., et al. “Hantavirus pulmonary syndrome in traveler returning from Nepal to Spain”. Emerging Infectious Diseases 1 (2020): 150-153.
  6. Priya AJ., et al. “Physical fitness among the dental physician, dental undergraduates and postgraduates students”. Indian Journal of Public Health Research and Development10 (2019): 223-226.
  7. Swathy S and Sethu VG. “Acupuncture and lower back pain”. Research Journal of Pharmacy and Technology8 (2015): 991-993.
  8. Timothy CN., et al. “Evaluation of peak expiratory flow rate (PEFR) in pet owners”. Indian Journal of Public Health Research and Development8 (2019): 803-806.
  9. Renuka S and Sethu G. “Regeneration after myocardial infarction”. Research Journal of Pharmacy and Technology6 (2015): 738-741.
  10. Jiang H., et al. “Hantavirus infection: a global zoonotic challenge”. Virologica Sinica1 (2017): 32-43.
  11. Vaheri A., et al. “Hantavirus infections in Europe and their impact on public health”. Reviews in Medical Virology 1 (2013): 35-49.
  12. Chandy S and Mathai D. “Globally emerging hantaviruses: An overview”. Indian Journal of Medical Microbiology 2 (2017): 165-175.
  13. Hentonnen H and Buchy P. “Hantavirus genetic diversity”. Infection, Genetics and Evolution (2012).
  14. Gravinatti ML., et al. “Synanthropic rodents as virus reservoirs and transmitters”. Revista da Sociedade Brasileira de Medicina Tropical 53 (2020): e20190486.
  15. Muranyi W., et al. “Hantavirus infection”. Journal of the American Society of Nephrology 12 (2005): 3669-3679.
  16. Johnson KM. “Hantaviruses: history and overview”. Current Topics in Microbiology and Immunology 256 (2001): 1-14.
  17. Mir MA. “Hantaviruses”. Clinics in Laboratory Medicine 1 (2010): 67-91.
  18. Escutenaire S and Pastoret PP. “Hantavirus infections”. Revue Scientifique et Technique 1 (2000): 64-78.
  19. McCAUGHEY C and Hart CA. “Hantaviruses”. Journal of Medical Microbiology 7 (2000): 587-599.
  20. Rodriguez-Moran P., et al. “Hantavirus infection in the Four Corners region of USA in 1998”. Lancet9137 (1998): 1353.
  21. Epidemiological Alert Hantavirus Pulmonary Syndrome in the Americas Region. Pan American Health Organization (WHO) (2025).
  22. “Hantavirus-hit cruise ship to sail to Spain rare andes strain confirmed”. Reuters (2026).
  23. Avšič-Županc T., et al. “Hantavirus infections”. Clinical Microbiology and Infection 21S (2013): e6-e16.
  24. Shruthi M and Preetha S. “Effect of simple tongue exercises in habitual snorers”. Research Journal of Pharmacy and Technology8 (2018): 3614-3616.
  25. Choudhari S and Jothipriya MA. “Non-alcoholic fatty liver disease”. Research Journal of Pharmacy and Technology10 (2016): 1782-1785.
  26. Muranyi W., et al. “Hantavirus infection”. Journal of the American Society of Nephrology 12 (2005): 3669-3679.
  27. Infection prevention and control of hantavirus infection, including Andes virus disease. Interim regional guidance for suspected or confirmed cases PAHO/PHE/IHM/26-0002 Pan American Health Organization (2026).
  28. Gayatri DR and Sethu G. “Evaluation of adenoids by oronasal and nasal spirometry”. Asian Journal of Pharmaceutical and Clinical Research10 (2018): 272.
  29. Maes P., et al. “Hantaviruses: immunology, treatment, and prevention”. Viral Immunology 4 (2004): 481-497.
  30. Valentijn Vergote., et al. “Chloroquine, an anti-malaria drug as effective prevention for hantavirus infections”. Frontiers in Cellular and Infection Microbiology 11 (2021): 580532.

Ruqaiyah J Hussain and Suleiman Al-Obeid., et al. “Hantavirus Infections: A Mini-Review of the Literature”. EC Microbiology 22.7 (2026): 01-08.

ECronicon Journal

Our Services

Quick Links

Information

Creative Commons LicenseOpen Access by ECronicon is licensed under a Creative Commons Attribution 4.0 International License
Based on a work at www.ecronicon.net